A controversial approach in both France and Britain, gaining momentum on social media and in the United States.

We’ve observed that many of our British clients seeking weight loss are turning to the use of molecules initially prescribed for type 2 diabetes treatment: semaglutide, marketed as Ozempic and Wegovy; tirzepatide (Mounjaro, Zepbound); and liraglutide (Saxenda). Administered via subcutaneous injections, these molecules regulate insulin production, affecting sugar metabolism and inducing satiety by slowing gastric emptying and inhibiting hunger signals.

But what’s the issue if it works?

These multi-faceted molecules are recognized in the healthcare sector and are prescribed solely for two chronic conditions: type 2 diabetes (Ozempic – Saxenda – Mounjaro); and obesity with associated comorbidities (Wegovy – Zepbound). Their indications are clearly defined within the medical community, and they are not currently available to the general public. The current media hype surrounding these molecules represents a deviation from their intended use.

However, some online pharmacies dispense these products, prompting discomfort within the healthcare sector. Issues include supply chain tensions, consumer frustration at denied access to these perceived miracle drugs, and the risk of counterfeit products flooding the market.

As therapists, our influence on clients may lead them to question our stance. While our role isn’t to take a definitive position, we must stay informed about existing practices and current health recommendations. It’s our duty not to trivialize the use of medicinal substances and to emphasize the necessity of medical advice, which can provide genuine support in weight-loss processes.

Just as we advocate for a holistic approach to well-being, we endeavor to inform our clients that weight gain or loss can stem from various factors—physiological, physical, emotional, and environmental. As AXO therapists, we have a public health role to fulfill, and acknowledging our limitations in health advice demonstrates professionalism.

Let’s open the dialogue on this weighty topic and navigate it with insight and cultural sensitivity.



Comments are closed

en_GBEnglish (UK)